Brain Damage
Oxygen and pressure to benefit brain health

Oxygen and pressure to benefit brain health

A recent systematic review published in the journal Frontiers in Neurology discovered that hyperbaric oxygen therapy could be a very effective and safe therapy option for mild traumatic brain injuries (mTBI). The review was conducted by Dr. Paul G. Harch, a clinical...

NC veterans with TBI, PTSD to receive free hyperbaric oxygen treatments

NC veterans with TBI, PTSD to receive free hyperbaric oxygen treatments

Extivita RTP is finding success using hyperbaric oxygen therapy (HBOT) to treat veterans who suffer from post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI).  Under Senate Bill 422, and in collaboration with The Community Foundation of NC East,...

Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans

Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans

The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.